PepsiCo fired the starting gun on Q2 2026 earnings today, reporting before the bell. It is one of the first major S&P 500 names to report this quarter. Delta Air Lines follows tomorrow with its Q2 results. Travel demand and fuel costs will be under the microscope. Next week brings the bigger wave. Bank of America reports Tuesday July 14. Johnson & Johnson and managed care giant Elevance Health follow on Wednesday July 15. Options markets are already pricing in elevated risk. ELV carries a short availability reading of 6,507% — a sign of heavy bearish positioning ahead of results.
Short sellers are not waiting for earnings season to pass. CoreWeave short interest jumped nearly 4 points in one week. It now sits at 32.7% of free float. is even more extreme at 75.4%. remains a textbook squeeze candidate, with short interest above 116% of its entire free float and zero availability to borrow.
Salesforce and Bio-Techne both drew fresh downgrades Wednesday. Salesforce's average target now stands at $245.60. Bio-Techne's new consensus target is $70. Salesforce also carries the highest short interest among large-cap software peers at 4.8% of free float.
H&M's founding Persson family filed over $160M in purchases of H&M shares last week. That bold bet contrasts sharply with Kingboard Holdings, where insiders filed over $920M in sales as the Hong Kong stock slid. Meanwhile, Elon Musk's $1.5M SEC settlement won court approval today — the judge signed off despite noting "significant misgivings."
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
